Showing results (1941-1950 of 4,573) with videos related to

Sort By:
Pageof 458
Journal of Evolutionary Biology|June 4, 2011
The opportunity for sexual selection: not mismeasured, just misunderstoodA H Krakauer, M S Webster, E H Duval, et al.
Meat Science|November 9, 2011
Use of a fluorescence front face technique for measurement of lipid oxidation during refrigerated storage of chicken meatPhilippe Gatellier, Suzana Gomez, Vérane Gigaud, et al.
Bioorganic & Medicinal Chemistry|November 15, 2011
Molecular drug-organiser: synthesis, characterization and biological evaluation of penicillin V and/or nalidixic acid calixarene-based podandsAdel Ben Salem, Guillaume Sautrey, Stéphane Fontanay, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 30, 2009
Bats in the bedroom, bats in the belfry: reanalysis of the rationale for rabies postexposure prophylaxisGaston De Serres, Danuta M Skowronski, Pierre Mimault, et al.
European Journal of Emergency Medicine : Official Journal of the European Society for Emergency Medicine|January 6, 2001
Unilateral fixed dilated pupil in a ventilated child with asthmaS D Geraerts, F B Plötz, C van Goor, et al.
The Journal of Family Practice|May 1, 1984
The maximum exercise stress test: is it a behavior-modification tool?D A Driggers, J Swedberg, R Johnson, et al.
Canadian Journal of Microbiology|January 1, 1984
Ecological distribution of Legionellaceae in the Quebec city areaJ R Joly, M Boissinot, J Duchaine, et al.
International Journal for Parasitology|February 19, 2011
An example of molecular co-evolution: reactive oxygen species (ROS) and ROS scavenger levels in Schistosoma mansoni/Biomphalaria glabrata interactionsYves Moné, Anne-Cécile Ribou, Céline Cosseau, et al.
Journal of Applied Toxicology : JAT|September 3, 2010
Inhibition of creatine kinase activity by 3-butyl-1-phenyl-2-(phenyltelluro)oct-en-1-one in the cerebral cortex and cerebellum of young ratsRodrigo Binkowski de Andrade, Tanise Gemelli, Robson Brum Guerra, et al.
Journal of Clinical Pharmacology|July 18, 2015
A phase-1, open-label, single-dose study of the pharmacokinetics of buparlisib in subjects with mild to severe hepatic impairmentDenes Csonka, Katharine Hazell, Edward Waldron, et al.
Pageof 458